Evidence map›Paper›PMID 32336023›Full record

ArticleProteomics2020

Time Course of Changes in Sorafenib-Treated Hepatocellular Carcinoma Cells Suggests Involvement of Phospho-Regulated Signaling in Ferroptosis Induction.

Emily G Werth, Presha Rajbhandari, Brent R Stockwell, Lewis M Brown

Open access · greenAbstract read
In one paragraph

Article in Proteomics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Emily G WerthDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Presha RajbhandariDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Brent R StockwellDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.
Lewis M BrownDepartment of Biological Sciences, Columbia University, New York, NY, 10027, USA.ORCID 0000-0002-1864-3077
Abterra Biosciences (United States) · USColumbia University · US

Funding

Scientific ReagentsP01CA087497 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI PETRINI, JOHN HJ · 2000 to 2021
$35.4M
NRSA Training CoreTL1TR001875 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SPANN, MARISA N, TAYLOR, JACQUELYN Y · 2016 to 2025
$8.9M
Defining the functions and translational potential of ferroptosisR35CA209896 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2016 to 2022
$6.5M
Development of ferroptosis inhibitors for Huntington DiseaseR61NS109407 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI STOCKWELL, BRENT R. · 2019 to 2019
$400k
NCATS NIH HHS TL1 TR001875NCATS NIH HHS TL1 TR001875 (to P.R.)NCI NIH HHS P01 CA087497NCI NIH HHS R35 CA209896NINDS NIH HHS R61 NS109407
6 · The paper itself

Abstract

Ferroptosis is a form of regulated, non-apoptotic cell death characterized by excessive lipid peroxidation that can be triggered by inhibition of the cystine-glutamate antiporter, system X

Indexed as

Carcinoma, HepatocellularCell Line, TumorDNA-Binding ProteinsFerritinsFerroptosisGene Expression Regulation, NeoplasticHeme Oxygenase-1HomeostasisHumansIronLipid PeroxidationLiver NeoplasmsOxidoreductasesPhosphoproteinsPhosphorylationProtein Kinase InhibitorsDNA-Binding ProteinsFerritinsFTH1 protein, humanHeme Oxygenase-1HMOX1 protein, humanIronOxidoreductasesPCBP1 protein, humanPhosphoproteinsProtein Kinase InhibitorsRNA-Binding ProteinsSorafenibferroptosishepatocellular carcimnomamass spectrometryphosphoproteomicsproteomics

Identifiers

PMID32336023
PMCPMC7305944
OpenAlexW3019879316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.